HPV-Associated Oropharyngeal Cancer · Symptoms & diagnosis

What are the early signs of HPV-associated oropharyngeal cancer?

Reviewed: 8 November 2026 By: Xiangpeng Liu, MD Topic: HPV-Associated Oropharyngeal Cancer Answer length: short, citable
Quick answer

The common early signs are a painless, often cystic lump in the upper neck (frequently the first and only sign), persistent sore throat or a sensation of a lump in the throat beyond 2–3 weeks, difficulty or pain on swallowing, or pain radiating to one ear (referred otalgia) and one tonsil larger or firmer than the other, or a visible tonsil ulcer. Head and neck tumours often cause mild, one-sided symptoms that mimic a cold, a dental problem or a sore throat. Any symptom in the head or neck that persists for more than two to three weeks needs an ENT examination rather than repeated antibiotics.

In detail

Early disease can be painless, which is why the "two-to-three-week rule" is used: a persistent lump, ulcer, hoarseness, unilateral ear pain, nasal obstruction or swallowing change should be examined with an endoscope by an ENT or head and neck specialist.

Do not wait for pain. Pain is usually a later feature in head and neck oncology, and delay in diagnosis is one of the strongest modifiable predictors of stage at presentation.

  • A painless, often cystic lump in the upper neck (frequently the first and only sign)
  • Persistent sore throat or a sensation of a lump in the throat beyond 2–3 weeks
  • Difficulty or pain on swallowing, or pain radiating to one ear (referred otalgia)
  • One tonsil larger or firmer than the other, or a visible tonsil ulcer
  • Change in voice, muffled "hot potato" speech or new snoring
  • Unexplained weight loss, fatigue or a persistent cough in advanced disease

What this means in practice: this answer is part of the “Symptoms & diagnosis” section of the HPV-Associated Oropharyngeal Cancer topic. If you are comparing treatment options, also read how to compare a second opinion and which records to send.

Other common questions about HPV-associated oropharyngeal cancer

See all 16 questions in this topic →

Sources for this answer

  1. Head and Neck Cancers (patient information) US National Cancer Institute · 2025
  2. About Head and Neck Cancer American Cancer Society · 2025
  3. Global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2022 CA: A Cancer Journal for Clinicians · 2026 · Subsite-level estimates for 185 countries; the basis of the regional atlas on this site.
  4. HPV & Oropharyngeal Cancer US National Institute of Dental and Craniofacial Research · 2025 · About 70% of oropharyngeal cancers in the United States are HPV-positive.
  5. HPV Detection in Oropharyngeal Cancer: A Narrative Review PubMed Central / peer-reviewed review · 2025 · HPV-attributable fraction: ~71% US, ~52% UK, >60% Scandinavia, <20% Southern Europe, ~44% globally.
  6. Impact of screening for HPV-positive oropharyngeal cancers: a microsimulation-based modeling study Journal of the National Cancer Institute · 2025 · Reports ~85% 5-year overall survival for HPV-positive oropharyngeal cancer.

Written and medically reviewed by Xiangpeng Liu, MD

Associate Chief Physician, ENT & Head/Neck Surgery · Chenzhou First People’s Hospital, Chenzhou, Hunan, China

Editorial policy & reviewer credentials · All sources

Need an opinion on your own case?

International patients can request a preliminary review based on pathology and imaging before travelling to China.

How the pathway works Send an enquiry

Medical disclaimer: This knowledge base is general information for people researching head and neck tumours, not a diagnosis or treatment plan. It does not replace an examination by a qualified physician. Survival figures are population averages, not predictions for an individual. Treatment and cost estimates for China are illustrative only and must be confirmed in writing after your records have been reviewed. If you have a symptom lasting more than two to three weeks, see a doctor promptly.